|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-7-23
|
|
pubmed:abstractText |
A prostate cancer (PCa) biomarker with improved specificity relative to PSA is a public health priority. Hypermethylated DNA can be detected in body fluids from PCa patients and may be a useful biomarker, although clinical performance varies between studies. We investigated the performance of candidate PCa DNA methylation biomarkers identified through a genome-wide search.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/DNA,
http://linkedlifedata.com/resource/pubmed/chemical/GSTP1 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Glutathione S-Transferase pi,
http://linkedlifedata.com/resource/pubmed/chemical/Histones,
http://linkedlifedata.com/resource/pubmed/chemical/Prostate-Specific Antigen,
http://linkedlifedata.com/resource/pubmed/chemical/RASSF2 protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/TFAP2E protein, human,
http://linkedlifedata.com/resource/pubmed/chemical/Transcription Factor AP-2,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Markers, Biological,
http://linkedlifedata.com/resource/pubmed/chemical/Tumor Suppressor Proteins
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
1097-0045
|
|
pubmed:author |
pubmed-author:DayJ KevinJK,
pubmed-author:KamradtJornJ,
pubmed-author:LiebenbergVolkerV,
pubmed-author:LograssoJoeJ,
pubmed-author:ModelFabianF,
pubmed-author:MorottiAndrewA,
pubmed-author:PayneShannon RSR,
pubmed-author:SchostakMartinM,
pubmed-author:SemjonowAxelA,
pubmed-author:SerthJurgenJ,
pubmed-author:SledziewskiAndrewA,
pubmed-author:StraussArneA,
pubmed-author:ThelenPaulP,
pubmed-author:YamamuraSuS
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
1
|
|
pubmed:volume |
69
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1257-69
|
|
pubmed:meshHeading |
pubmed-meshheading:19459176-Adult,
pubmed-meshheading:19459176-Aged,
pubmed-meshheading:19459176-Cytodiagnosis,
pubmed-meshheading:19459176-DNA,
pubmed-meshheading:19459176-DNA Methylation,
pubmed-meshheading:19459176-Glutathione S-Transferase pi,
pubmed-meshheading:19459176-Histones,
pubmed-meshheading:19459176-Humans,
pubmed-meshheading:19459176-Male,
pubmed-meshheading:19459176-Middle Aged,
pubmed-meshheading:19459176-Predictive Value of Tests,
pubmed-meshheading:19459176-Prostate-Specific Antigen,
pubmed-meshheading:19459176-Prostatic Neoplasms,
pubmed-meshheading:19459176-Transcription Factor AP-2,
pubmed-meshheading:19459176-Tumor Markers, Biological,
pubmed-meshheading:19459176-Tumor Suppressor Proteins,
pubmed-meshheading:19459176-Urinalysis,
pubmed-meshheading:19459176-Young Adult
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
DNA methylation biomarkers of prostate cancer: confirmation of candidates and evidence urine is the most sensitive body fluid for non-invasive detection.
|
|
pubmed:affiliation |
Epigenomics, Inc., Seattle, Washington 98101, USA. shannon.payne@epigenomics.com
|
|
pubmed:publicationType |
Journal Article
|
